dc.contributor.author |
Huber, Stephan M. |
|
dc.contributor.author |
Klumpp, Dominik |
|
dc.contributor.author |
Stegen, Benjamin |
|
dc.contributor.author |
Schraermeyer, Ulrich |
|
dc.contributor.author |
Tschulakow, Alexander Viktor |
|
dc.contributor.author |
Dittmann, Klaus Herman |
|
dc.contributor.author |
Rodemann, Hans Peter |
|
dc.contributor.author |
Julien-Schraermeyer, Sylvie |
|
dc.date.accessioned |
2019-05-07T13:23:39Z |
|
dc.date.available |
2019-05-07T13:23:39Z |
|
dc.date.issued |
2017 |
|
dc.identifier.issn |
0167-8140 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/88423 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Elsevier Ireland Ltd |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1016/j.radonc.2017.06.023 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
The radioprotector ortho-phospho-L-tyrosine (pTyr) attenuates the side effects of fractionated irradiation in retinoblastoma mouse models but also decreases the local tumour control |
de_DE |
dc.type |
Article |
de_DE |
dc.type |
ConferenceObject |
de_DE |
utue.quellen.id |
20190131163842_01267 |
|
utue.publikation.seiten |
462-467 |
de_DE |
utue.personen.roh |
Tschulakow, Alexander V. |
|
utue.personen.roh |
Dittmann, Klaus |
|
utue.personen.roh |
Huber, Stephan M. |
|
utue.personen.roh |
Klumpp, Dominik |
|
utue.personen.roh |
Stegen, Benjamin |
|
utue.personen.roh |
Schraermeyer, Ulrich |
|
utue.personen.roh |
Rodemann, H. Peter |
|
utue.personen.roh |
Julien-Schraermeyer, Sylvie |
|
dcterms.isPartOf.ZSTitelID |
Radiotherapy and Oncology |
de_DE |
dcterms.isPartOf.ZS-Issue |
3 |
de_DE |
dcterms.isPartOf.ZS-Volume |
124 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |